Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Daily News

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

L.A. McKeown

August 21, 2024

News Daily News

Device Correction Issued for HeartMate Monitor Due to Potential Pump Stoppage

Todd Neale

June 28, 2024

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

News Daily News

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Michael O'Riordan

June 21, 2022

News Daily News

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

Michael O'Riordan

April 15, 2021

News Daily News

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

L.A. McKeown

July 27, 2020

News Daily News

Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive

Yael L. Maxwell

December 19, 2019

News Daily News

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

L.A. McKeown

November 02, 2018

News Daily News

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Michael O'Riordan

October 03, 2018

News Daily News

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Yael L. Maxwell

March 01, 2018

News Daily News

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Caitlin E. Cox

September 29, 2017

News Daily News

FDA Grants HeartWare LVAD a Destination Therapy Indication

Todd Neale

September 28, 2017

News Daily News

TCTMD’s Top 10 Most Popular Stories for June 2017

Shelley Wood

July 03, 2017

News Daily News

Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI

Michael O'Riordan

August 24, 2016

News Daily News

Fewer Adverse Events with Radial vs. Femoral PCI in High-Risk IABP Patients

Jason Kahn

October 25, 2013

Advertisement

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

FDA Approves Dropping Aspirin for HeartMate 3 LVAD Patients

Device Correction Issued for HeartMate Monitor Due to Potential Pump Stoppage

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Hints of Benefit With Levosimendan in Pulmonary Hypertension Due to HFpEF

ViV TAVR Beats Redo SAVR for Short- but Not Long-term Outcomes

Optimal Implantation Depth With Self-Expanding TAVR? Success May Prove Elusive

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

FDA Grants HeartWare LVAD a Destination Therapy Indication

TCTMD’s Top 10 Most Popular Stories for June 2017

Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI

Fewer Adverse Events with Radial vs. Femoral PCI in High-Risk IABP Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content